Search Results - "LODDER, L. N"

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? by LODDER, L. N, FRETS, P. G, CORNELISSE, C. J, NIERMEIJER, M. F, TRIJSBURG, R. W, MEIJERS-HEIJBOER, E. J, KLIJN, J. G. M, DUIVENVOORDEN, H. J, TIBBEN, A, WAGNER, A, VAN DER MEER, C. A, DEVILEE, P

“…Presymptomatic DNA testing for autosomal dominant hereditary breast/ovarian cancer (HBOC) became an option after the identification of the BRCA1 and BRCA2…”
Get full text

Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands by Lodder, L N, Frets, P G, Trijsburg, R W, Meijers-Heijboer, E J, Klijn, J G, Niermeijer, M F

Get full text

Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders by DUDOKDEWIT, A. C, TIBBEN, A, DUIVENVOORDEN, H. J, FRETS, P. G, ZOETEWEIJ, M. W, LOSEKOOT, M, VAN HAERINGEN, A, NIERMEIJER, M. F, PASSCHIER, J

Get full text

Predicting adaptation to presymptomatic DNA testing for late onset disorders : Who will experience distress? by WIT, A. C. D, TIBBEN, A, DUIVENVOORDEN, H. J, NIERMEIJER, M. F, PASSCHIER, J

Get full text

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery) by LODDER, Litanja N, FRETS, Petra G, BREKELMANS, Cecile T. M, BURGER, Curt W, NIERMEIJER, Martinus F, TRIJSBURG, R. Willem, MEIJERS-HEIJBOER, E. Johanna, KLIJN, Jan G. M, SEYNAEVE, Caroline, VAN GEEL, Albertus N, TILANUS, Madeleine M. A, BARTELS, Carina C. M, VERHOOG, Leon C

“…Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whether they have inherited the gene mutation (BRCA1/BRCA2), and…”
Get full text

Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: Comparing questionnaire results with in-depth interviews by DudokdeWit, A. Christine, Tibben, Aad, Duivenvoorden, Hugo J., Niermeijer, Martinus F., Passchier, Jan, Trijsburg, R. Willem

“…In 50% risk carriers for Huntington disease (n = 41), hereditary cerebral hemorrhage with amyloidosis Dutch‐type (n = 9) familial adenomatous polyposis coli (n…”
Get full text

Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for theBRCA1/BRCA2 gene mutation in The Netherlands by LODDER, L N, FRETS, P G, TRIJSBURG, R W, MEIJERS-HEIJBOER, E J, KLIJN, J G M, NIERMEIJER, M F

“…[...]mutation carriers may be more acutely aware of the burdensome emotional implications of terminating a pregnancy because ofBRCA1/BRCA2carriership than…”
Get full text

Presymptomatic testing for BRCA1 andBRCA2: how distressing are the pre-test weeks? by Lodder, L N, Frets, P G, Trijsburg, R W, Meijers-Heijboer, E J, Klijn, J G M, Duivenvoorden, H J, Tibben, A, Wagner, A, van der Meer, C A, Devilee, P, Cornelisse, C J, Niermeijer, M F

“…Presymptomatic DNA testing for autosomal dominant hereditary breast/ovarian cancer (HBOC) became an option after the identification of the BRCA1 andBRCA2 genes…”
Get full text

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group by Lodder, L N, Frets, P G, Trijsburg, R W, Meijers-Heijboer, E J, Klijn, J G, Duivenvoorden, H J, Tibben, A, Wagner, A, van der Meer, C A, Devilee, P, Cornelisse, C J, Niermeijer, M F

“…Presymptomatic DNA testing for autosomal dominant hereditary breast/ovarian cancer (HBOC) became an option after the identification of the BRCA1 and BRCA2…”
Get full text

Response to correspondence from Coyne-"Benign mental health consequences of screening for mutations of BRCA1/BRCA2" by Lodder, Litanja N., Trijsburg, R.W., Frets, Petra G., Niermeijer, Martinus F.

Get full text